Retension Pharmaceuticals is a healthcare company.
Retension Pharmaceuticals has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
Retension Pharmaceuticals's investors include Collage Partners.
Retension Pharmaceuticals is headquartered in Falls Church, United States.
Retension Pharmaceuticals is a healthcare company.
Retension Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Retension Pharmaceuticals — Funding & Investors." VCBacked, April 22, 2025, https://www.vcbacked.co/company/retension-pharmaceuticals. Accessed November 6, 2026.
VCBacked. (2025). Retension Pharmaceuticals — Funding & Investors. Retrieved November 6, 2026, from https://www.vcbacked.co/company/retension-pharmaceuticals
{{cite web |title=Retension Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/retension-pharmaceuticals |website=VCBacked |access-date=November 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Retension Pharmaceuticals? Request a listing update